Ubiquitin conjugating enzymes, or UBE2s, are a class of enzymes that play a pivotal role in the ubiquitin-proteasome system, a highly regulated and essential pathway responsible for the targeted degradation of proteins within eukaryotic cells. UBE2s are responsible for the conjugation of ubiquitin molecules to specific protein substrates, marking them for degradation by the proteasome or participating in various other cellular processes, such as DNA repair and cell cycle regulation. UBE2s operate in conjunction with ubiquitin-activating enzymes (E1s) and ubiquitin ligases (E3s) to facilitate the transfer of ubiquitin molecules onto protein substrates. This covalent attachment of ubiquitin tags serves as a signal for recognition and subsequent proteasomal degradation or involvement in other ubiquitin-mediated processes.
UBE2 inhibitors are a class of compounds designed to interfere with the enzymatic activity of UBE2s. These inhibitors may function through various mechanisms, such as binding directly to UBE2 enzymes, disrupting their interactions with E1s and E3s, or blocking the transfer of ubiquitin molecules to protein substrates. The development and study of UBE2 inhibitors are crucial for understanding the intricacies of the ubiquitin-proteasome system and its regulation. By modulating UBE2 activity, researchers can gain insights into the specific roles of UBE2s in various cellular pathways and the consequences of inhibiting their function. This knowledge contributes to a deeper understanding of protein turnover, post-translational modification, and cellular homeostasis, with implications for drug discovery and basic research in cell biology and molecular biology.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
Ginkgolic acid C17:1 | 111047-30-4 | sc-228252 sc-228252A sc-228252B | 5 mg 10 mg 20 mg | $279.00 $452.00 $834.00 | 2 | |
L'acide ginkgolique inhibe l'UBE2 en modifiant de manière covalente la cystéine de son site actif, en interférant avec la formation du complexe UBE2~SUMO thioester et en bloquant ensuite la SUMOylation. | ||||||
2-D08 | 144707-18-6 | sc-507405 | 5 mg | $150.00 | ||
Le 2-D08 est un inhibiteur allostérique de l'UBE2 qui se lie à un site distinct du site actif, provoquant des changements de conformation qui entravent la formation de thioesters E2~SUMO et la SUMOylation. | ||||||
Uridine 5′-monophosphate disodium salt | 3387-36-8 | sc-222403 sc-222403A | 1 g 5 g | $51.00 $122.00 | ||
L'inhibiteur II de l'UBE2 cible le site de liaison du thioester E2~SUMO, bloquant l'interaction avec la SUMO ligase et interférant avec les processus de SUMOylation. | ||||||
NSC697923 | 343351-67-7 | sc-391107 sc-391107A | 1 mg 5 mg | $15.00 $51.00 | 3 | |
Le NSC697923 est une petite molécule inhibitrice qui perturbe l'assemblage du complexe des LCR en ciblant l'enzyme activatrice de la protéine ubiquitine ligase. En inhibant l'ubiquitination médiée par les LCR, il stabilise les protéines clés impliquées dans le contrôle du cycle cellulaire et la réparation de l'ADN, ce qui entraîne l'arrêt du cycle cellulaire et l'apoptose. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
TAK-243 est un inhibiteur sélectif de l'enzyme activatrice de la protéine ubiquitine ligase (NAE). Il perturbe la néddylation des cullin-RING ligases (CRLs), ce qui entraîne l'accumulation des substrats des CRLs, conduisant à l'arrêt du cycle cellulaire et à l'apoptose. | ||||||